Participant information

Recruitment to the ReSoLuCENT study was completed in August 2016. Ethical approval for the study was extended to 2022 to allow continued analysis of the data and samples generously donated by participants. This valuable data was used in research projects worldwide.

All the projects which requested to use ReSoLuCENT data required ethical approval and this was agreed by the Trial Management Group, which included a patient representative.

Researchers can request access to information on the study database and to the blood and tissue samples. No information indentifying individual participants in ReSoLuCENT is passed on to other researchers. Any data used for research analysis is supplied using anonymous Study ID numbers allocated at the time participants joined the study.

If you wish to withdraw from the database at any time please contact the study coordinator Angela Cox: a.cox@sheffield.ac.uk.